4.1. 相关说明及支持文件(点击查看) Related Explanatory & Supporting Documents (Click to view)
ChineseVer-Celzyva在研药物未来上市后销售额-中国内地小于10%_20260904.pdf
Estimated Future Sales of Celzyva-mainland China less than 10%_20260904.PDF
《Celzyva的设施设备、原材料、 生产和技术等对中国内地无任何依赖性》
Celzyva's facilities, equipment, raw materials, manufacturing operations, and technologies are fully independent of Mainland China
《Celzyva的设施与设备》
Celzyva's Facilities & Instruments
《Celzyva‑Hong Kong与中国内地泉生公司共同研发以降低成本;共同研发中国内外知识产权和商业权益的归属》
Celzyva and Mainland‑China Shanghai Quansheng Company conducted co‑development to reduce costs; the ex‑mainland China intellectual property rights and commercial interests arising from the co‑development belong Celzyva‑Hong Kong






